Suppr超能文献

成人百日咳疫苗接种:临床医生最新指南

Pertussis Vaccination for Adults: An Updated Guide for Clinicians.

作者信息

See Kay Choong

机构信息

Division of Respiratory and Critical Care Medicine, Department of Medicine, National University Hospital, Singapore 119074, Singapore.

出版信息

Vaccines (Basel). 2025 Jan 11;13(1):60. doi: 10.3390/vaccines13010060.

Abstract

Pertussis, or whooping cough, is a highly contagious respiratory infection caused by the Gram-negative bacterium . Although traditionally associated with children, pertussis is increasingly prevalent among adults, particularly those with comorbidities or weakened immune systems, where it can lead to severe complications. Diagnosing pertussis in adults can be challenging due to its nonspecific symptoms, underreporting, and the limited sensitivity of available diagnostic tests. While treatment with macrolides is generally effective, it may not significantly alter the clinical course of the disease, and growing concerns about macrolide resistance are emerging. Vaccination remains the cornerstone of prevention, offering proven immunogenicity, efficacy, and safety. However, vaccination uptake remains low, partly due to limited patient awareness and insufficient prioritization by healthcare professionals. This review aims to provide clinicians with critical insights into pertussis epidemiology, vaccination strategies, and the latest guideline recommendations, empowering them to engage in meaningful discussions with adult patients and advocate for increased vaccination to combat this often-overlooked infection.

摘要

百日咳,又称小儿咳嗽,是由革兰氏阴性菌引起的一种高度传染性的呼吸道感染。虽然传统上与儿童有关,但百日咳在成年人中越来越普遍,尤其是那些患有合并症或免疫系统较弱的人,在这些人群中,百日咳可能会导致严重的并发症。由于成人百日咳的症状不具特异性、报告不足以及现有诊断测试的敏感性有限,因此在成人中诊断百日咳具有挑战性。虽然使用大环内酯类药物治疗通常有效,但它可能不会显著改变疾病的临床进程,并且人们对大环内酯类耐药性的担忧日益增加。疫苗接种仍然是预防的基石,具有已证实的免疫原性、有效性和安全性。然而,疫苗接种率仍然很低,部分原因是患者意识有限以及医疗保健专业人员的重视不足。本综述旨在为临床医生提供关于百日咳流行病学、疫苗接种策略和最新指南建议的重要见解,使他们能够与成年患者进行有意义的讨论,并倡导增加疫苗接种以对抗这种经常被忽视的感染。

相似文献

1
Pertussis Vaccination for Adults: An Updated Guide for Clinicians.
Vaccines (Basel). 2025 Jan 11;13(1):60. doi: 10.3390/vaccines13010060.
2
Immunogenicity and safety of reduced-antigen tetanus, diphtheria and acellular pertussis vaccination in adults treated for obstructive airway diseases.
Hum Vaccin Immunother. 2023 Dec 31;19(1):2159731. doi: 10.1080/21645515.2022.2159731. Epub 2023 Feb 6.
4
The need for pertussis vaccination among older adults and high-risk groups: a perspective from advanced economies of the Asia Pacific region.
Expert Rev Vaccines. 2021 Dec;20(12):1603-1617. doi: 10.1080/14760584.2021.1990759. Epub 2021 Nov 22.
10
Pertussis Epidemiology in Children: The Role of Maternal Immunization.
Vaccines (Basel). 2024 Sep 9;12(9):1030. doi: 10.3390/vaccines12091030.

引用本文的文献

1
Atypical Presentation of Bordetella pertussis in a Six-Month-Old with Cleaved Lymphocytes and Mild Respiratory Distress.
Cureus. 2025 Jun 5;17(6):e85395. doi: 10.7759/cureus.85395. eCollection 2025 Jun.
3
Exploiting subtractive genomics to identify novel drug targets and new immunogenic candidates against : an study.
Front Bioinform. 2025 May 13;5:1570054. doi: 10.3389/fbinf.2025.1570054. eCollection 2025.

本文引用的文献

1
Pertussis vaccination in adults: a behavioral study of physicians from the US, France, and Germany.
BMC Prim Care. 2024 Nov 26;25(1):402. doi: 10.1186/s12875-024-02647-3.
2
Seroepidemiology of pertussis immunity in five provinces of China: A population-based, cross-sectional study.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2417532. doi: 10.1080/21645515.2024.2417532. Epub 2024 Nov 15.
5
Global tendency and frontiers of research on pertussis from 2000 to 2023: A bibliometric and visual analysis.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2392334. doi: 10.1080/21645515.2024.2392334. Epub 2024 Sep 5.
6
2024 ESC Guidelines for the management of chronic coronary syndromes.
Eur Heart J. 2024 Sep 29;45(36):3415-3537. doi: 10.1093/eurheartj/ehae177.
7
Pertussis upsurge, age shift and vaccine escape post-COVID-19 caused by ptxP3 macrolide-resistant Bordetella pertussis MT28 clone in China.
Clin Microbiol Infect. 2024 Nov;30(11):1439-1446. doi: 10.1016/j.cmi.2024.08.016. Epub 2024 Aug 28.
8
Resurgence of , including one macrolide-resistant isolate, France, 2024.
Euro Surveill. 2024 Aug;29(31). doi: 10.2807/1560-7917.ES.2024.29.31.2400459.
9
Adult vaccination coverage in the United States: A database analysis and literature review of improvement strategies.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2381283. doi: 10.1080/21645515.2024.2381283. Epub 2024 Jul 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验